조현병을 처음 진단받은 환자들의 초기 투약 순응도에 따른 발병 1년 후 임상 결과: 국민건강보험공단 자료에 기반한 후향적 코호트 연구

키워드

참고문헌 (45)

1. Saha S, "A systematic review of the prevalence of schizophrenia", PLoS Med, 2, pp.e141~ (2005)
2. Chong HY, "Global economic burden of schizophrenia : a systematic review", Neuropsychiatr Dis Treat, 12, pp.357~373 (2016)
3. Sung Joon Cho, "Annual Prevalence and Incidence of Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A National Health Insurance Data-Based Study", PSYCHIATRY INVESTIGATION, 17(1), pp.61~70 (2020), 대한신경정신의학회[DOI]
4. Jo M, "The cost-of-illness trend of schizophrenia in South Korea from 2006 to 2016", PLoS One, 15, pp.e0235736~ (2020)
5. McGorry PD, "Early intervention in psychosis:concepts, evidence and future directions", World Psychiatry, 7, pp.148~156 (2008)
6. Marshall M, "Early intervention for psychosis", Cochrane Database Syst Rev (2011)
7. 박종익, "정신질환에 대한 사회적 편견", 신경정신의학, 55(4), pp.299~309 (2016), 대한신경정신의학회[DOI]
8. Kane JM, "Psychopharmacologic Treatment of Schizophrenia", Schizophrenia Bulletin, 19, pp.287~302 (1993)
9. Dixon LB, "Conventional Antipsychotic Medications for Schizophrenia", Schizophrenia Bulletin, 21, pp.567~577 (1995)
10. Geddes J, "Atypical antipsychotics in the treatment of schizophrenia : systematic overview and meta-regression analysis", BMJ, 321, pp.1371~ (2000)
11. Tiihonen J, "Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder : observational follow-up study", BMJ, 333, pp.224~ (2006)
12. Leucht S, "Antipsychotic drugs versus placebo for relapse prevention in schizophrenia : a systematic review and meta-analysis", The Lancet, 379, pp.2063~2071 (2012)
13. Higashi K, "Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review", Ther Adv Psychopharmacol, 3, pp.200~218 (2013)
14. Leclerc E, "Determinants of adherence to treatment in first-episode psychosis : a comprehensive review", Braz J Psychiatry, 37, pp.168~176 (2015)
15. Knapp M, "Non-adherence to antipsychotic medication regimens : associations with resource use and costs", Br J Psychiatry, 184, pp.509~516 (2004)
16. Rittmannsberger H, "Medication adherence among psychotic patients before admission to inpatient treatment", Psychiatr Serv, 55, pp.174~179 (2004)
17. Valenstein M, "Pharmacy Data Identify Poorly Adherent Patients with Schizophrenia at Increased Risk for Admission", Medical Care, 40, pp.630~639 (2002)
18. Eaddy M, "Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population", Clin Ther, 27, pp.263~272 (2005)
19. Lang K, "Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics", Psychiatr Serv, 61, pp.1239~1247 (2010)
20. Offord S, "Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia", Adv Ther, 30, pp.286~297 (2013)
21. Kuwabara H, "Adherence and rehospitalizations in patients with schizophrenia : evidence from Japanese claims data", Neuropsychiatr Dis Treat, 11, pp.935~940 (2015)
22. Hardy M, "Antipsychotic adherence and emergency department utilization among patients with schizophrenia", Schizophr Res, 201, pp.347~351 (2018)
23. 조맹제, "Prevalence and Correlates of DSM-IV Mental Disorders in South Korean Adults: The Korean Epidemiologic Catchment Area Study 2011", PSYCHIATRY INVESTIGATION, 12(2), pp.164~170 (2015), 대한신경정신의학회[DOI]
24. 허정운, "정신병적 장애로 첫 내원한 환자들의 임상 특징과 투약 순응도 및 의료 이용 추이: 예비 연구", 대한조현병학회지, 22(2), pp.35~50 (2019), 대한조현병학회[DOI]
25. Sung Joon Cho, "Adherence to Antipsychotic Drugs by Medication Possession Ratio for Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A Retrospective Cohort Study", Clinical Psychopharmacology and Neuroscience, 20(3), pp.491~497 (2022), 대한정신약물학회[DOI]
26. Boden R, "Early nonadherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder", Schizophr Res, 133, pp.36~41 (2011)
27. 김지애, "Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data", Journal of Korean Medical Science, 32(5), pp.718~728 (2017), 대한의학회
28. Steiner JF, "A general method of compliance assessment using centralized pharmacy records. Description and validation", Med Care, 26, pp.814~823 (1988)
29. Valenstein M, "Poor antipsychotic adherence among patients with schizophrenia : medication and patient factors", Schizophr Bull, 30, pp.255~264 (2004)
30. Weiden PJ, "Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia", Psychiatr Serv, 55, pp.886~891 (2004)
31. Vollmer WM, "Comparison of pharmacy-based measures of medication adherence", BMC Health Serv Res, 12, pp.155~ (2012)
32. Grossman LS, "Sex differences in schizophrenia and other psychotic disorders : a 20-year longitudinal study of psychosis and recovery", Compr Psychiatry, 49, pp.523~529 (2008)
33. Vila-Rodriguez F, "Complex interaction between symptoms, social factors, and gender in social functioning in a community-dwelling sample of schizophrenia", Psychiatr Q, 82, pp.261~274 (2011)
34. Bozikas VP, "Sex differences in neuropsychological functioning among schizophrenia patients", Aust N Z J Psychiatry, 44, pp.333~341 (2010)
35. Vaskinn A, "Sex differences in neuropsychological performance and social functioning in schizophrenia and bipolar disorder", Neuropsychology, 25, pp.499~510 (2011)
36. Yang J, "Symptom severity and attitudes toward medication : impacts on adherence in outpatients with schizophrenia", Schizophr Res, 134, pp.226~231 (2012)
37. Coldham EL, "Medication adherence of individuals with a first episode of psychosis", Acta Psychiatr Scand, 106, pp.286~290 (2002)
38. Häfner H, "The Influence of Age and Sex on the Onset and Early Course of Schizophrenia", The British Journal of Psychiatry, 162, pp.80~86 (1993)
39. Burns T, "Evolution of outcome measures in schizophrenia", The British Journal of Psychiatry, 191, pp.s1~ (2007)[DOI]
40. Burns T, "Hospitalisation as an outcome measure in schizophrenia", The British Journal of Psychiatry, 191, pp.s37~s41 (2007)
41. Addington DE, "Validity of hospital admission as an outcome measure of services for first-episode psychosis", Psychiatr Serv, 63, pp.280~282 (2012)
42. Woo JH, "Frequent Users of Hospital Emergency Departments in Korea Characterized by Claims Data from the National Health Insurance : A Cross Sectional Study", PLOS ONE, 11, pp.e0147450~ (2016)
43. Blonde L, "Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician", Adv Ther, 35, pp.1763~1774 (2018)
44. Go DS, "A Review of the Admission System for Mental Disorders in South Korea", Int J Environ Res Public Health, 17, pp.9159~ (2020)
45. Kim AM., "Psychiatric hospitalization in Korea, 2011-2020: the impact of the Mental Health Act revision of 2017 in consideration of the COVID-19 pandemic", Asian J Psychiatr, 68, pp.102934~ (2022)

관련 논문AI추천